168 related articles for article (PubMed ID: 10408973)
1. The CTLA-4 gene is associated with multiple sclerosis.
Ligers A; Xu C; Saarinen S; Hillert J; Olerup O
J Neuroimmunol; 1999 Jun; 97(1-2):182-90. PubMed ID: 10408973
[TBL] [Abstract][Full Text] [Related]
2. CTLA4 promoter and exon 1 dimorphisms in multiple sclerosis.
Harbo HF; Celius EG; Vartdal F; Spurkland A
Tissue Antigens; 1999 Jan; 53(1):106-10. PubMed ID: 10082437
[TBL] [Abstract][Full Text] [Related]
3. No evidence to support CTLA-4 as a susceptibility gene in MS families: the Canadian Collaborative Study.
Dyment DA; Steckley JL; Willer CJ; Armstrong H; Sadovnick AD; Risch N; Ebers GC
J Neuroimmunol; 2002 Feb; 123(1-2):193-8. PubMed ID: 11880164
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic T-lymphocyte antigen 4 gene polymorphisms in sarcoidosis patients.
Hattori N; Niimi T; Sato S; Achiwa H; Maeda H; Oguri T; Bessho Y; Ito H; Shimizu S; Ueda R
Sarcoidosis Vasc Diffuse Lung Dis; 2005 Mar; 22(1):27-32. PubMed ID: 15881277
[TBL] [Abstract][Full Text] [Related]
5. Relation of three polymorphisms of the CTLA-4 gene in patients with Graves' disease.
Kouki T; Gardine CA; Yanagawa T; Degroot LJ
J Endocrinol Invest; 2002 Mar; 25(3):208-13. PubMed ID: 11936461
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms and susceptibility to type 1 autoimmune hepatitis.
Agarwal K; Czaja AJ; Jones DE; Donaldson PT
Hepatology; 2000 Jan; 31(1):49-53. PubMed ID: 10613727
[TBL] [Abstract][Full Text] [Related]
7. CTLA4 is associated with susceptibility to multiple sclerosis.
Kantarci OH; Hebrink DD; Achenbach SJ; Atkinson EJ; Waliszewska A; Buckle G; McMurray CT; de Andrade M; Hafler DA; Weinshenker BG
J Neuroimmunol; 2003 Jan; 134(1-2):133-41. PubMed ID: 12507781
[TBL] [Abstract][Full Text] [Related]
8. Genetic interaction of CTLA-4 with HLA-DR15 in multiple sclerosis patients.
Alizadeh M; Babron MC; Birebent B; Matsuda F; Quelvennec E; Liblau R; Cournu-Rebeix I; Momigliano-Richiardi P; Sequeiros J; Yaouanq J; Genin E; Vasilescu A; Bougerie H; Trojano M; Martins Silva B; Maciel P; Clerget-Darpoux F; Clanet M; Edan G; Fontaine B; Semana G
Ann Neurol; 2003 Jul; 54(1):119-22. PubMed ID: 12838528
[TBL] [Abstract][Full Text] [Related]
9. CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms.
Ligers A; Teleshova N; Masterman T; Huang WX; Hillert J
Genes Immun; 2001 May; 2(3):145-52. PubMed ID: 11426323
[TBL] [Abstract][Full Text] [Related]
10. No association of polymorphisms of the CTLA-4 exon 1(+49) and promoter(-318) genes with rheumatoid arthritis in the Korean population.
Lee YH; Choi SJ; Ji JD; Song GG
Scand J Rheumatol; 2002; 31(5):266-70. PubMed ID: 12455815
[TBL] [Abstract][Full Text] [Related]
11. [Polymorphism A/G in position +49 of CTLA4 exon 1 in multiple sclerosis in Russians].
Andreevskiĭ TV; Sudomoina MA; Gusev EI; Boĭko AN; Alekseenkov AD; Favorova OO
Mol Biol (Mosk); 2002; 36(4):643-8. PubMed ID: 12173468
[TBL] [Abstract][Full Text] [Related]
12. CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease.
Kouki T; Sawai Y; Gardine CA; Fisfalen ME; Alegre ML; DeGroot LJ
J Immunol; 2000 Dec; 165(11):6606-11. PubMed ID: 11086105
[TBL] [Abstract][Full Text] [Related]
13. CTLA-4 gene polymorphism may modulate disease in Japanese multiple sclerosis patients.
Fukazawa T; Yanagawa T; Kikuchi S; Yabe I; Sasaki H; Hamada T; Miyasaka K; Gomi K; Tashiro K
J Neurol Sci; 1999 Dec; 171(1):49-55. PubMed ID: 10567049
[TBL] [Abstract][Full Text] [Related]
14. CTLA4 exon 1 dimorphism is associated with primary progressive multiple sclerosis.
Mäurer M; Ponath A; Kruse N; Rieckmann P
J Neuroimmunol; 2002 Oct; 131(1-2):213-5. PubMed ID: 12458055
[TBL] [Abstract][Full Text] [Related]
15. A single nucleotide polymorphism in exon 1 of cytotoxic T-lymphocyte-associated-4 (CTLA-4) is not associated with rheumatoid arthritis.
Barton A; Myerscough A; John S; Gonzalez-Gay M; Ollier W; Worthington J
Rheumatology (Oxford); 2000 Jan; 39(1):63-6. PubMed ID: 10662875
[TBL] [Abstract][Full Text] [Related]
16. Polymorphism in the promoter and exon 1 of the cytotoxic T lymphocyte antigen-4 gene associated with autoimmune thyroid disease in Koreans.
Park YJ; Chung HK; Park DJ; Kim WB; Kim SW; Koh JJ; Cho BY
Thyroid; 2000 Jun; 10(6):453-9. PubMed ID: 10907987
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxic T lymphocyte antigen 4 (CTLA-4) dimorphism in patients with systemic lupus erythematosus.
Pullmann R; Lukác J; Skerenová M; Rovensky J; Hybenová J; Melus V; Celec S; Pullmann R; Hyrdel R
Clin Exp Rheumatol; 1999; 17(6):725-9. PubMed ID: 10609073
[TBL] [Abstract][Full Text] [Related]
18. Progression of multiple sclerosis is associated with exon 1 CTLA-4 gene polymorphism.
Bilińska M; Frydecka I; Noga L; Dobosz T; Zołedziewska M; Suwalska K; Tutak A; Pokryszko-Dragan A
Acta Neurol Scand; 2004 Jul; 110(1):67-71. PubMed ID: 15180809
[TBL] [Abstract][Full Text] [Related]
19. CTLA4 dimorphisms and the multiple sclerosis phenotype.
Masterman T; Ligers A; Zhang Z; Hellgren D; Salter H; Anvret M; Hillert J
J Neuroimmunol; 2002 Oct; 131(1-2):208-12. PubMed ID: 12458054
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms of the CTLA-4 exon 1 and promoter gene in systemic lupus erythematosus.
Lee YH; Kim YR; Ji JD; Sohn J; Song GG
Lupus; 2001; 10(9):601-5. PubMed ID: 11678447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
